HeimBiotek Recognized as Top Tech Company in Life and Health at 2024 China Overseas Talent Innovation and Entrepreneurship Competition
HeimBiotek has been selected as the "Top Tech Company" in Life and Health at the "2024 China Overseas Talent Innovation and Entrepreneurship Competition," held in Nanning, China, from the 11th~13th of July.
This competition provides a platform for participants to showcase their technology and innovation, with outstanding projects receiving substantial support. The event was hosted by the China Association for Science and Technology and the People's Government of Guangxi Zhuang Autonomous Region, and co-organized by several organizations, including the China International Science and Technology Exchange Center, Guangxi Association for Science and Technology, Nanning People's Government, Nanning Association for Science and Technology, National Offshore Innovation and Entrepreneurship for Overseas Professionals (Nanning), and Shanghai Oracle Bay Group.
The competition featured five categories: Life and Health, Information Technology, Green and Low-Carbon, Advanced Manufacturing, and Future Industry and Cultural Creativity, with a total of 2032 project submissions from 50 countries. 136 outstanding projects from 24 countries advanced to the finals with 10 teams from each track being selected for the Innovation and Entrepreneurship List.
HeimBiotek was recognized as the "Top Tech Company" for its HB miRDx™ EarlyHCC Kit, which utilizes circulating miRNA biomarkers for early-stage liver cancer (stages 1-2) diagnosis. The HB miRDx™ EarlyHCC Kit has concluded exploratory clinical trials, having demonstrated significant results in two clinical experiments with a total of 500 samples. Preparation are currently underway for confirmatory clinical trials with the Ministry of Food and Drug Safety of the Republic of South Korea.
